Finasteride Tablets USP, 1 mg, Rx Only, Packaged as: a) 30-count bottle NDC 16729-089-10…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Recalling firm

Accord Healthcare, Inc.

NDC code

16729-089-10

Origin

NC, United States

Initiated by

Voluntary: Firm initiated

FDA recall number

D-0390-2023

Other Finasteride recalls

See all

Class II · Moderate risk Ongoing Feb 7, 2025

Finasteride NDC# 82187-1003-1 Container Description: The product packed in white poly bag containing black poly bag and tied…

Reason CGMP Deviations

Aspen Biopharma Labs Pvt., Ltd. NDC 82187-1003-1 D-0262-2025

Class II · Moderate risk Ongoing Mar 23, 2023

Finasteride Tablets, USP, 5 mg, packaged in: a) 30-count bottles (NDC 68788-6976-3); b) 90-count bottles (NDC 68788-6976-9), Rx…

Reason cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.

Preferred Pharmaceuticals, Inc. NDC 68788-6976-3 D-0516-2023

Class II · Moderate risk Terminated Mar 13, 2023

Finasteride, USP, 5 mg Tablets, Rx Only, Packaged as a 90-count bottle, NDC 61919-0733-90; Packaged and Distributed By: Direct Rx

Reason cGMP deviations

Direct Rx NDC 61919-0733-90 D-0477-2023

Class II · Moderate risk Terminated Feb 7, 2023

Finasteride Tablets USP, 5 mg, Rx Only, Packaged as: a) 30-count bottles NDC 16729-090-10 UPC 3 16729 09010 0; b) 90-count…

Reason CGMP Deviations: recalling drug products following an FDA inspection.

Accord Healthcare, Inc. NDC 16729-090-10 D-0392-2023

Class II · Moderate risk Terminated Feb 7, 2023

Finasteride Tablets USP 1 mg, 90-count bottle, Keeps, Rx Only, Manufactured for: Thirty Madison, Inc. New York, NY 10016…

Reason CGMP Deviations: recalling drug products following an FDA inspection.

Accord Healthcare, Inc. NDC 71713-096-90 D-0391-2023